Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study

In aging humans, night levels of melatonin (MEL) decline progressively. Also thyroid and gonadal functions decline during aging while gonadotropins (luteotropic hormone (LH) and follicle stimulating hormone (FSH)) steadily increase. A desynchronization of pineal circadian cyclicity as expressed by t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental gerontology 2001-02, Vol.36 (2), p.297-310
Hauptverfasser: Bellipanni, G, Bianchi, P, Pierpaoli, W, Bulian, D, Ilyia, E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 310
container_issue 2
container_start_page 297
container_title Experimental gerontology
container_volume 36
creator Bellipanni, G
Bianchi, P
Pierpaoli, W
Bulian, D
Ilyia, E
description In aging humans, night levels of melatonin (MEL) decline progressively. Also thyroid and gonadal functions decline during aging while gonadotropins (luteotropic hormone (LH) and follicle stimulating hormone (FSH)) steadily increase. A desynchronization of pineal circadian cyclicity as expressed by the progressive decrease of the MEL night peak may be permissively linked to the onset and progression of menopause. We studied the effects of exogenous, evening administration of MEL on the level of hormones which are known to be involved in the genesis and progression of menopause. Perimenopausal and menopausal women from 42 to 62 years of age with no pathology or medication were selected. MEL was measured in saliva to divide them into low, medium and high-MEL patients. Half of them took 3 mg MEL and half of them Placebo at bedtime (10–12 p.m.) in a fully randomized and double-blind fashion. Three and six months later blood was taken for determination of pituitary (LH, FSH), ovarian, and thyroid hormones I(T 3 and T 4). All women taking MEL with low basal level of MEL and/or Placebo for three and six months showed a significant increase in levels of thyroid hormones. Before initiation of the study, a negative correlation was found in all women between LH, FSH and basal MEL levels. Within six months of treatment, MEL produced a significant diminution of LH in the younger women (43 to 49 year-old), while no effect was seen in the older women (50–62 years old). A decrement of FSH was observed in MEL-treated women with low basal MEL levels. In addition, most MEL-treated women reported a general improvement of mood and a significant mitigation of depression. MEL decline during aging may thus signal the derangement of pineal and pituitary-controlled ovarian cyclicity and the progressive quenching of fertility in women. These findings seem to show a recovery of pituitary and thyroid functions in MEL-treated women, towards a more juvenile pattern of regulation.
doi_str_mv 10.1016/S0531-5565(00)00217-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70651782</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0531556500002175</els_id><sourcerecordid>70651782</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-97222ba86e0d26a18a763b247f1e50dfe82ebda59f8cdbe54702c092b75178723</originalsourceid><addsrcrecordid>eNqFkE1r3DAQQEVJaDbb_oQGn0J7cDKSLcnbSyjL5gMWckh7FrI0AhfbciW7YfPrK-8uaW6BgWGkNzPMI-QLhSsKVFw_AS9ozrngXwG-ATAqc_6BLGgli1xUlJ-QxStyRs5j_A0AghX0IzmjlDEhy3JB3MY5NGPMvMs6bPXo-6bPUgwYmg57P-gp6jbTvc3elM8-Fd8znYX04bvmBe0eGVptsPaZ8f0YfNum5zhOdveJnDrdRvx8zEvy63bzc32fbx_vHtY_trkpi2rMV5IxVutKIFgmNK20FEXNSukocrAOK4a11XzlKmNr5KUEZmDFasmprCQrluTyMHcI_s-EcVRdEw22re7RT1FJEDM5g_wAmuBjDOjUkO7VYacoqFmw2gtWsz0FoPaCFU99F8cFU92h_d91NJqAmwOA6cy_DQYVTYO9QduEJFpZ37yz4h-gjoul</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70651782</pqid></control><display><type>article</type><title>Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Bellipanni, G ; Bianchi, P ; Pierpaoli, W ; Bulian, D ; Ilyia, E</creator><creatorcontrib>Bellipanni, G ; Bianchi, P ; Pierpaoli, W ; Bulian, D ; Ilyia, E</creatorcontrib><description>In aging humans, night levels of melatonin (MEL) decline progressively. Also thyroid and gonadal functions decline during aging while gonadotropins (luteotropic hormone (LH) and follicle stimulating hormone (FSH)) steadily increase. A desynchronization of pineal circadian cyclicity as expressed by the progressive decrease of the MEL night peak may be permissively linked to the onset and progression of menopause. We studied the effects of exogenous, evening administration of MEL on the level of hormones which are known to be involved in the genesis and progression of menopause. Perimenopausal and menopausal women from 42 to 62 years of age with no pathology or medication were selected. MEL was measured in saliva to divide them into low, medium and high-MEL patients. Half of them took 3 mg MEL and half of them Placebo at bedtime (10–12 p.m.) in a fully randomized and double-blind fashion. Three and six months later blood was taken for determination of pituitary (LH, FSH), ovarian, and thyroid hormones I(T 3 and T 4). All women taking MEL with low basal level of MEL and/or Placebo for three and six months showed a significant increase in levels of thyroid hormones. Before initiation of the study, a negative correlation was found in all women between LH, FSH and basal MEL levels. Within six months of treatment, MEL produced a significant diminution of LH in the younger women (43 to 49 year-old), while no effect was seen in the older women (50–62 years old). A decrement of FSH was observed in MEL-treated women with low basal MEL levels. In addition, most MEL-treated women reported a general improvement of mood and a significant mitigation of depression. MEL decline during aging may thus signal the derangement of pineal and pituitary-controlled ovarian cyclicity and the progressive quenching of fertility in women. These findings seem to show a recovery of pituitary and thyroid functions in MEL-treated women, towards a more juvenile pattern of regulation.</description><identifier>ISSN: 0531-5565</identifier><identifier>EISSN: 1873-6815</identifier><identifier>DOI: 10.1016/S0531-5565(00)00217-5</identifier><identifier>PMID: 11226744</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Adult ; Affect - drug effects ; Circadian Rhythm - drug effects ; Circadian Rhythm - physiology ; Depression ; Depression - drug therapy ; Double-Blind Method ; Female ; Follicle Stimulating Hormone - blood ; Gonadal Steroid Hormones - blood ; Gonadotropins ; Humans ; Luteinizing Hormone - blood ; Melatonin ; Melatonin - administration &amp; dosage ; Melatonin - pharmacology ; Melatonin - physiology ; Menopause - drug effects ; Menopause - physiology ; Menopause - psychology ; Menstrual Cycle - drug effects ; Middle Aged ; Perimenopause ; Pineal gland ; Premenopause - drug effects ; Premenopause - physiology ; Premenopause - psychology ; Thyroid function ; Thyrotropin - blood ; Thyroxine - blood ; Triiodothyronine - blood</subject><ispartof>Experimental gerontology, 2001-02, Vol.36 (2), p.297-310</ispartof><rights>2001 Elsevier Science Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-97222ba86e0d26a18a763b247f1e50dfe82ebda59f8cdbe54702c092b75178723</citedby><cites>FETCH-LOGICAL-c438t-97222ba86e0d26a18a763b247f1e50dfe82ebda59f8cdbe54702c092b75178723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0531556500002175$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11226744$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bellipanni, G</creatorcontrib><creatorcontrib>Bianchi, P</creatorcontrib><creatorcontrib>Pierpaoli, W</creatorcontrib><creatorcontrib>Bulian, D</creatorcontrib><creatorcontrib>Ilyia, E</creatorcontrib><title>Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study</title><title>Experimental gerontology</title><addtitle>Exp Gerontol</addtitle><description>In aging humans, night levels of melatonin (MEL) decline progressively. Also thyroid and gonadal functions decline during aging while gonadotropins (luteotropic hormone (LH) and follicle stimulating hormone (FSH)) steadily increase. A desynchronization of pineal circadian cyclicity as expressed by the progressive decrease of the MEL night peak may be permissively linked to the onset and progression of menopause. We studied the effects of exogenous, evening administration of MEL on the level of hormones which are known to be involved in the genesis and progression of menopause. Perimenopausal and menopausal women from 42 to 62 years of age with no pathology or medication were selected. MEL was measured in saliva to divide them into low, medium and high-MEL patients. Half of them took 3 mg MEL and half of them Placebo at bedtime (10–12 p.m.) in a fully randomized and double-blind fashion. Three and six months later blood was taken for determination of pituitary (LH, FSH), ovarian, and thyroid hormones I(T 3 and T 4). All women taking MEL with low basal level of MEL and/or Placebo for three and six months showed a significant increase in levels of thyroid hormones. Before initiation of the study, a negative correlation was found in all women between LH, FSH and basal MEL levels. Within six months of treatment, MEL produced a significant diminution of LH in the younger women (43 to 49 year-old), while no effect was seen in the older women (50–62 years old). A decrement of FSH was observed in MEL-treated women with low basal MEL levels. In addition, most MEL-treated women reported a general improvement of mood and a significant mitigation of depression. MEL decline during aging may thus signal the derangement of pineal and pituitary-controlled ovarian cyclicity and the progressive quenching of fertility in women. These findings seem to show a recovery of pituitary and thyroid functions in MEL-treated women, towards a more juvenile pattern of regulation.</description><subject>Adult</subject><subject>Affect - drug effects</subject><subject>Circadian Rhythm - drug effects</subject><subject>Circadian Rhythm - physiology</subject><subject>Depression</subject><subject>Depression - drug therapy</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Follicle Stimulating Hormone - blood</subject><subject>Gonadal Steroid Hormones - blood</subject><subject>Gonadotropins</subject><subject>Humans</subject><subject>Luteinizing Hormone - blood</subject><subject>Melatonin</subject><subject>Melatonin - administration &amp; dosage</subject><subject>Melatonin - pharmacology</subject><subject>Melatonin - physiology</subject><subject>Menopause - drug effects</subject><subject>Menopause - physiology</subject><subject>Menopause - psychology</subject><subject>Menstrual Cycle - drug effects</subject><subject>Middle Aged</subject><subject>Perimenopause</subject><subject>Pineal gland</subject><subject>Premenopause - drug effects</subject><subject>Premenopause - physiology</subject><subject>Premenopause - psychology</subject><subject>Thyroid function</subject><subject>Thyrotropin - blood</subject><subject>Thyroxine - blood</subject><subject>Triiodothyronine - blood</subject><issn>0531-5565</issn><issn>1873-6815</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1r3DAQQEVJaDbb_oQGn0J7cDKSLcnbSyjL5gMWckh7FrI0AhfbciW7YfPrK-8uaW6BgWGkNzPMI-QLhSsKVFw_AS9ozrngXwG-ATAqc_6BLGgli1xUlJ-QxStyRs5j_A0AghX0IzmjlDEhy3JB3MY5NGPMvMs6bPXo-6bPUgwYmg57P-gp6jbTvc3elM8-Fd8znYX04bvmBe0eGVptsPaZ8f0YfNum5zhOdveJnDrdRvx8zEvy63bzc32fbx_vHtY_trkpi2rMV5IxVutKIFgmNK20FEXNSukocrAOK4a11XzlKmNr5KUEZmDFasmprCQrluTyMHcI_s-EcVRdEw22re7RT1FJEDM5g_wAmuBjDOjUkO7VYacoqFmw2gtWsz0FoPaCFU99F8cFU92h_d91NJqAmwOA6cy_DQYVTYO9QduEJFpZ37yz4h-gjoul</recordid><startdate>20010201</startdate><enddate>20010201</enddate><creator>Bellipanni, G</creator><creator>Bianchi, P</creator><creator>Pierpaoli, W</creator><creator>Bulian, D</creator><creator>Ilyia, E</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010201</creationdate><title>Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study</title><author>Bellipanni, G ; Bianchi, P ; Pierpaoli, W ; Bulian, D ; Ilyia, E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-97222ba86e0d26a18a763b247f1e50dfe82ebda59f8cdbe54702c092b75178723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Affect - drug effects</topic><topic>Circadian Rhythm - drug effects</topic><topic>Circadian Rhythm - physiology</topic><topic>Depression</topic><topic>Depression - drug therapy</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Follicle Stimulating Hormone - blood</topic><topic>Gonadal Steroid Hormones - blood</topic><topic>Gonadotropins</topic><topic>Humans</topic><topic>Luteinizing Hormone - blood</topic><topic>Melatonin</topic><topic>Melatonin - administration &amp; dosage</topic><topic>Melatonin - pharmacology</topic><topic>Melatonin - physiology</topic><topic>Menopause - drug effects</topic><topic>Menopause - physiology</topic><topic>Menopause - psychology</topic><topic>Menstrual Cycle - drug effects</topic><topic>Middle Aged</topic><topic>Perimenopause</topic><topic>Pineal gland</topic><topic>Premenopause - drug effects</topic><topic>Premenopause - physiology</topic><topic>Premenopause - psychology</topic><topic>Thyroid function</topic><topic>Thyrotropin - blood</topic><topic>Thyroxine - blood</topic><topic>Triiodothyronine - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bellipanni, G</creatorcontrib><creatorcontrib>Bianchi, P</creatorcontrib><creatorcontrib>Pierpaoli, W</creatorcontrib><creatorcontrib>Bulian, D</creatorcontrib><creatorcontrib>Ilyia, E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental gerontology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bellipanni, G</au><au>Bianchi, P</au><au>Pierpaoli, W</au><au>Bulian, D</au><au>Ilyia, E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study</atitle><jtitle>Experimental gerontology</jtitle><addtitle>Exp Gerontol</addtitle><date>2001-02-01</date><risdate>2001</risdate><volume>36</volume><issue>2</issue><spage>297</spage><epage>310</epage><pages>297-310</pages><issn>0531-5565</issn><eissn>1873-6815</eissn><abstract>In aging humans, night levels of melatonin (MEL) decline progressively. Also thyroid and gonadal functions decline during aging while gonadotropins (luteotropic hormone (LH) and follicle stimulating hormone (FSH)) steadily increase. A desynchronization of pineal circadian cyclicity as expressed by the progressive decrease of the MEL night peak may be permissively linked to the onset and progression of menopause. We studied the effects of exogenous, evening administration of MEL on the level of hormones which are known to be involved in the genesis and progression of menopause. Perimenopausal and menopausal women from 42 to 62 years of age with no pathology or medication were selected. MEL was measured in saliva to divide them into low, medium and high-MEL patients. Half of them took 3 mg MEL and half of them Placebo at bedtime (10–12 p.m.) in a fully randomized and double-blind fashion. Three and six months later blood was taken for determination of pituitary (LH, FSH), ovarian, and thyroid hormones I(T 3 and T 4). All women taking MEL with low basal level of MEL and/or Placebo for three and six months showed a significant increase in levels of thyroid hormones. Before initiation of the study, a negative correlation was found in all women between LH, FSH and basal MEL levels. Within six months of treatment, MEL produced a significant diminution of LH in the younger women (43 to 49 year-old), while no effect was seen in the older women (50–62 years old). A decrement of FSH was observed in MEL-treated women with low basal MEL levels. In addition, most MEL-treated women reported a general improvement of mood and a significant mitigation of depression. MEL decline during aging may thus signal the derangement of pineal and pituitary-controlled ovarian cyclicity and the progressive quenching of fertility in women. These findings seem to show a recovery of pituitary and thyroid functions in MEL-treated women, towards a more juvenile pattern of regulation.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>11226744</pmid><doi>10.1016/S0531-5565(00)00217-5</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0531-5565
ispartof Experimental gerontology, 2001-02, Vol.36 (2), p.297-310
issn 0531-5565
1873-6815
language eng
recordid cdi_proquest_miscellaneous_70651782
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adult
Affect - drug effects
Circadian Rhythm - drug effects
Circadian Rhythm - physiology
Depression
Depression - drug therapy
Double-Blind Method
Female
Follicle Stimulating Hormone - blood
Gonadal Steroid Hormones - blood
Gonadotropins
Humans
Luteinizing Hormone - blood
Melatonin
Melatonin - administration & dosage
Melatonin - pharmacology
Melatonin - physiology
Menopause - drug effects
Menopause - physiology
Menopause - psychology
Menstrual Cycle - drug effects
Middle Aged
Perimenopause
Pineal gland
Premenopause - drug effects
Premenopause - physiology
Premenopause - psychology
Thyroid function
Thyrotropin - blood
Thyroxine - blood
Triiodothyronine - blood
title Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T17%3A09%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20melatonin%20in%20perimenopausal%20and%20menopausal%20women:%20a%20randomized%20and%20placebo%20controlled%20study&rft.jtitle=Experimental%20gerontology&rft.au=Bellipanni,%20G&rft.date=2001-02-01&rft.volume=36&rft.issue=2&rft.spage=297&rft.epage=310&rft.pages=297-310&rft.issn=0531-5565&rft.eissn=1873-6815&rft_id=info:doi/10.1016/S0531-5565(00)00217-5&rft_dat=%3Cproquest_cross%3E70651782%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70651782&rft_id=info:pmid/11226744&rft_els_id=S0531556500002175&rfr_iscdi=true